Literature DB >> 17371806

Genetic approaches identify differential roles for alpha4beta2* nicotinic receptors in acute models of antinociception in mice.

M I Damaj1, C Fonck, M J Marks, P Deshpande, C Labarca, H A Lester, A C Collins, B R Martin.   

Abstract

The effects of nicotine on the tail-flick and hot-plate tests were determined to identify nicotinic receptor subtypes responsible for spinally and supraspinally mediated nicotine analgesia in knockin mice expressing hypersensitive alpha(4) nicotinic receptors (L9'S), in seven inbred mouse strains (C57BL/6, DBA/2, A/2, CBA/2, BALB/cByJ, C3H/HeJ, and 129/SvEv), and in two F1 hybrids (B6CBAF1 and B6D2F1). L9'S heterozygotes were approximately 6-fold more sensitive to the antinociceptive effects of nicotine than the wild-type controls in the hot-plate test but not in the tail-flick assay. Large differences in the effects of nicotine were also observed with both tests for the seven mouse strains. A/J and 129 mice were 6- to 8-fold more sensitive than CBA and BALB mice. In addition, B6CBAF1 hybrid mice were even less sensitive than CBA mice. Nicotinic binding sites were measured in three spinal cord regions and the hindbrain of the inbred strains. Significant differences in cytisine-sensitive, high affinity [(125)I]epibatidine binding site levels (alpha(4)beta(2)(*) subtypes), but not in (125)I-alpha-bungarotoxin binding (alpha(7)(*) subtypes), were observed. Significant negative correlations between cytisine-sensitive [(125)I]epibatidine binding and nicotine ED(50) for both tests were noted. Our results indicate that alpha(4)beta(2)(*) acetylcholine nicotinic receptors (nAChR) are important in mediating nicotine analgesia in supraspinal responses, while also showing that alpha(4)beta(2)(*)-nAChR and at least one other nAChR subtype appear to modulate spinal actions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17371806     DOI: 10.1124/jpet.106.112649

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  33 in total

1.  Role of alpha5 nicotinic acetylcholine receptors in pharmacological and behavioral effects of nicotine in mice.

Authors:  K J Jackson; M J Marks; R E Vann; X Chen; T F Gamage; J A Warner; M I Damaj
Journal:  J Pharmacol Exp Ther       Date:  2010-04-16       Impact factor: 4.030

2.  The neuronal nicotinic alpha4beta2 receptor has a high maximal probability of being open.

Authors:  Ping Li; Joe H Steinbach
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Chronic nicotine cell specifically upregulates functional alpha 4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path.

Authors:  Raad Nashmi; Cheng Xiao; Purnima Deshpande; Sheri McKinney; Sharon R Grady; Paul Whiteaker; Qi Huang; Tristan McClure-Begley; Jon M Lindstrom; Cesar Labarca; Allan C Collins; Michael J Marks; Henry A Lester
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

4.  Behavioral modulation of neuronal calcium/calmodulin-dependent protein kinase II activity: differential effects on nicotine-induced spinal and supraspinal antinociception in mice.

Authors:  M Imad Damaj
Journal:  Biochem Pharmacol       Date:  2007-07-10       Impact factor: 5.858

5.  Altered nocifensive behavior in animal models of autism spectrum disorder: The role of the nicotinic cholinergic system.

Authors:  Li Wang; Luis E F Almeida; Margaret Nettleton; Alfia Khaibullina; Sarah Albani; Sayuri Kamimura; Mehdi Nouraie; Zenaide M N Quezado
Journal:  Neuropharmacology       Date:  2016-09-13       Impact factor: 5.250

6.  The nicotinic α6 subunit gene determines variability in chronic pain sensitivity via cross-inhibition of P2X2/3 receptors.

Authors:  Jeffrey S Wieskopf; Jayanti Mathur; Walrati Limapichat; Michael R Post; Mona Al-Qazzaz; Robert E Sorge; Loren J Martin; Dmitri V Zaykin; Shad B Smith; Kelen Freitas; Jean-Sebastien Austin; Feng Dai; Jie Zhang; Jaclyn Marcovitz; Alexander H Tuttle; Peter M Slepian; Sarah Clarke; Ryan M Drenan; Jeff Janes; Shakir Al Sharari; Samantha K Segall; Eske K Aasvang; Weike Lai; Reinhard Bittner; Christopher I Richards; Gary D Slade; Henrik Kehlet; John Walker; Uwe Maskos; Jean-Pierre Changeux; Marshall Devor; William Maixner; Luda Diatchenko; Inna Belfer; Dennis A Dougherty; Andrew I Su; Sarah C R Lummis; M Imad Damaj; Henry A Lester; Ardem Patapoutian; Jeffrey S Mogil
Journal:  Sci Transl Med       Date:  2015-05-13       Impact factor: 17.956

7.  Effects of nicotine deprivation on current pain intensity among daily cigarette smokers.

Authors:  Lisa R LaRowe; Jesse D Kosiba; Emily L Zale; Joseph W Ditre
Journal:  Exp Clin Psychopharmacol       Date:  2018-07-23       Impact factor: 3.157

8.  Pain as a predictor and consequence of tobacco abstinence effects amongst African American smokers.

Authors:  Mariel S Bello; Julia F McBeth; Joseph W Ditre; Matthew G Kirkpatrick; Lara A Ray; Kelly E Dunn; Adam M Leventhal
Journal:  J Abnorm Psychol       Date:  2018-08-02

Review 9.  Insights into the neurobiology of the nicotinic cholinergic system and nicotine addiction from mice expressing nicotinic receptors harboring gain-of-function mutations.

Authors:  Ryan M Drenan; Henry A Lester
Journal:  Pharmacol Rev       Date:  2012-08-10       Impact factor: 25.468

10.  Calcium/calmodulin-dependent protein kinase IV mediates acute nicotine-induced antinociception in acute thermal pain tests.

Authors:  Kia J Jackson; Mohamad I Damaj
Journal:  Behav Pharmacol       Date:  2013-12       Impact factor: 2.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.